Abstract
β-Adrenergic blocking drugs are increasingly being used in the field of psychiatry and neurology. This is best represented by the fact, that a symposium was devoted to them at the last world congress of psychiatry (Kielholz 1978). During the past years some of the indications tested were based on clinical results, while others emerged from rather experimental investigations. They can be divided into four major clinical areas, and are discussed in the order of their practical importance.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alcoff JM, Campbell D, Tribble D, Oldfield B, Cruess D (1981) Double-blind, placebo-controlled, crossover trial of propranolol as treatment for menopausal vasomotor symptoms. Clin Ther 3: 356–364
Arensberg D, Wenger NK (1979) Psychosis: a probable result of propranolol therapy. Int J Addict 14: 785–787
Atsmon A, Blum I, Wijsenbeek H, Maoz B, Ziegelman G (1971) The short-term effects of adrenergic-blocking agents in a small group of psychotic patients. Psychiatr Neurol Neurochir 74: 251–258
Carlsson C, Johansson T (1971) The psychological effects of propranolol in the abstinence phase of chronic alcoholics. Br J Psychiatr 119: 605
Castleden CM, Kaye CM, Parsons RL (1975) The effect of age on plasma levels of propranolol and practolol in man. Br J Clin Pharmacol 2: 303–306
Diamond S, Medina JL (1976) Double-blind study of propranolol for migraine prophylaxis. Headache 16: 24–27
Editorial (1979) β-blockers in essential tremor. Lancet II: 1280
Floru L, Floru L, Tegeler J (1974) Wirkung von β-Rezeptorenblockern (Pindolol and Practolol) auf den lithiumbedingten Tremor — Klinischer Versuch und theoretische Erwägungen. Arzneim Forsch 24: 1122–1125
Gastpar M (1976) Depressive anxiety. CIBA review: Anxiety and fear — their qualities and measurement.
Gastpar M, Hobi V, Pöldinger W, Goldsmith S, Maly V, Schmidlin PE (1980) A Placebo-controlled comparative study of the combined effects of Oxprenolol and clomipramine in depressed patients. Int Pharmacopsychiatr 15: 24–58
Grosz HJ (1972) Narcotic withdrawal symptoms in heroin users treated with propranolol. Lancet II: 564
Hanssen T, Heyden T, Sundberg I, Alfredsson G, Nybäck H, Wetterberg L (1980) Propranolol in schizophrenia. Arch Gen Psychiatry 37: 685–690
James JM et al. (1977) Lancet II: 952
Kielholz P (ed) (1978) A therapeutic approach to the psyche via the β-adrenergic system. Huber, Bern, p 9
Ladewig D, Levin P, Gastpar M, Gerking P, Roth E (1977) The use of β-blockers in the management of withdrawal syndromes. In: Kielholz P (ed) β-blockers and the central nervous system. Huber, Bern, p 149–157
Lange CG (1922) The emotions. A psychophysiological study. In: Lange CG, James W (eds) The emotions. Williams & Wilkins, Baltimore, p 33
Lehrl S, Blaha L, Erzigkeit H (1977) Einfluß von Oxprenolol auf die Affektlage in einer Prüfungssituation. Eine Verlaufsuntersuchung unter Doppelblindbedingungen. Arzneim Forsch 27: 429
Lindström LH, Persson E (1980) Propranolol in chronic schizophrenia: a controlled study in neuroleptic-treated patients. Br J Psychiatr 137: 126–130
Möller H-J, v Zerssen D, Emrich HM et al. (1979) Action of d-Propranolol in manic psychoses. Arch Psychiatr Nervenkr 227: 301–317
Neftel K (1980) Das Lampenfieber der Musiker: Ein Modell zur Wirkungsweise der β-blocker. Referat anläßlich des 20. Neuropsychiatrischen Symposiums in Pula/Jugoslawien
Reid JL, Briant RH (1977) An interaction between desmethylimipramine and Clonidine. In: Grahame-Smith DG (ed) Drug interactions. Macmillan, London Basingstoke, p 231–238
Remick RA, O’Kane J, Sparling TG (1981) A case report of toxic psychosis with low-dose propranolol therapy. Am J Psychiatry 138: 850–851
Resnick RB, Kestenbaum RS, Schwartz LK, Smith A (1976) Evaluation of propranolol in opiate dependence. Arch Gen Psychiatry 33: 993
Shand DJ (1976) Pharmacokinetics of propranolol: a review. Postgrad Med J [Suppl] 52: 22–25
Volk W, Bier W, Braun JP, Griiter W, Spiegelberg U (1972) Behandlung von erregten Psychosen mit einem β-Rezeptoren-Blocker (Oxprenolol) in hoher Dosierung. Nervenarzt 43: 491
Widroe T, Vigander T (1974) Propranolol in the treatment of migraine. Br Med J 2: 699–701
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Gastpar, M. (1982). The Role of β-Blockers in Psychiatry and Neurology with Special Reference to Older Patients. In: Lang, E., Sörgel, F., Blaha, L. (eds) Beta-Blockers in the Elderly. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68674-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-68674-0_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-11682-0
Online ISBN: 978-3-642-68674-0
eBook Packages: Springer Book Archive